Showing results (261-270 of 388) with videos related to
Sort By:
Pageof 39
Neuropathology and Applied Neurobiology|July 27, 2022
DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based studyElizabeth Schepke, Maja Löfgren, Torsten Pietsch, et al.Journal of Neurosurgery. Pediatrics|July 28, 2022
Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG 2004 cohortUlrich-Wilhelm Thomale, Astrid K Gnekow, Daniela Kandels, et al.Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation StatusMatthias Schneider, Anna-Laura Potthoff, Bernd O Evert, et al.Journal of Neuro-Oncology|March 6, 2013
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour studyDarren Hargrave, Birgit Geoerger, Didier Frappaz, et al.Neurology|February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphomaAgnieszka Korfel, Eckhard Thiel, Peter Martus, et al.Journal of Neuro-Oncology|October 17, 2021
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studiesJonas E Adolph, Gudrun Fleischhack, Christine Gaab, et al.Acta Neuropathologica|January 6, 2024
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytomaMichael Weller, Jörg Felsberg, Bettina Hentschel, et al.BMC Cancer|September 4, 2009
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyChristoph P Beier, Christina Schmid, Thierry Gorlia, et al.Plos One|September 5, 2008
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresMarcel Kool, Jan Koster, Jens Bunt, et al.Clinical Epigenetics|June 27, 2020
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanomaFriederike Hoffmann, Romina Zarbl, Dennis Niebel, et al.Pageof 39